For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
14 days Manufacturer Eptifibatide 2 mg/mL Integrilin (Schering) 60 days Prescribing information Erythromycin ethylsuccinate oral suspension EES (Abbott) 14 days Prescribing information Etanercept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback